-
-
-
-
-
-
-
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
-
-
-
-
-
-
-
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
-
-
-
-
-
-
-
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
-
-
-
-
-
-
-
QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025
-
-
-
-
-
-
-
Qiagen (QGEN) and Gencurix partner to develop oncology assays for QIAcuityDx platform
-
-
-
-
-
-
-
QIAGEN announces plans for transition in leadership of Supervisory Board
-
-
-
-
-
-
-
QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook
-
1,199,636 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

